Related Experiment Videos

Interleukin-4 antagonizes oncostatin M and transforming growth factor beta-induced responses in articular

Mohammed El Mabrouk1, Hamid Yaqoob Qureshi, Wen Qing Li

  • 1Department of Medicine and Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.

Journal of Cellular Biochemistry
|June 5, 2007
PubMed

Insights

Interleukin-4 (IL-4) inhibits cartilage-degrading enzymes in rheumatoid arthritis (RA) models. However, IL-4 also suppresses tissue inhibitor of metalloproteinase-3 (TIMP-3), warranting caution for its therapeutic use.

Area of Science:

  • Biochemistry
  • Immunology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) involves cartilage degradation mediated by matrix metalloproteinases (MMPs) and aggrecanases (ADAMTS).
  • Oncostatin M (OSM) and transforming growth factor beta 1 (TGF-beta1) are key cytokines in RA, inducing proteases and tissue inhibitor of metalloproteinase-3 (TIMP-3).
  • Interleukin-4 (IL-4) is an anti-inflammatory cytokine with potential cartilage-protective roles.

Purpose of the Study:

  • To investigate the cartilage protective mechanisms of interleukin-4 (IL-4) in the context of rheumatoid arthritis (RA).
  • To determine IL-4's effects on OSM- and TGF-beta1-induced gene expression and signaling pathways in chondrocytes.

Main Methods:

  • Chondrocytes were treated with OSM and/or TGF-beta1, with or without IL-4.
  • Gene expression of MMP-13, ADAMTS-4, and TIMP-3 was quantified.
  • Phosphorylation of signaling molecules including ERK, p38, JNK, and Stat1 was assessed.
  • Inhibitors of signaling pathways were used to probe mechanisms.

Main Results:

  • IL-4 significantly suppressed OSM-induced MMP-13 and TIMP-3 gene expression, and minimally suppressed ADAMTS-4.
  • IL-4 did not alter OSM-stimulated phosphorylation of ERK, p38, JNK, and Stat1.
  • IL-4 downregulated TGF-beta1-induced TIMP-3 expression and Smad2/JNK phosphorylation, with JNK inhibition further reducing TIMP-3 RNA.

Conclusions:

  • IL-4 exhibits cartilage-protective effects by inhibiting key cartilage-degrading enzymes (MMPs and ADAMTS-4) in RA models.
  • The suppression of TIMP-3 by IL-4, however, indicates a potential limitation for its use as a standalone cartilage-protective therapy.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...